Antibodies and methods for immunohistochemistry of extracellular matrix proteins

Matrix Biology

Volumn 71-72, Issue , 2018, Pages 10-27

  Rickelt, Steffen ^a   Hynes, Richard O ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Antibody validation; Extracellular matrix antibodies; Immunohistochemistry

Indexed keywords

ANTIBODY; SCLEROPROTEIN;

ANTIBODY SPECIFICITY; CLINICAL EFFECTIVENESS; EXTRACELLULAR MATRIX; GENOME ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEOMICS; REVIEW; STANDARDIZATION; VALIDATION STUDY; ANIMAL; DRUG INDUSTRY; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIBODIES; DRUG INDUSTRY; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 85047474446     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2018.04.011     Document Type: Review

References (66)

1. Mecham, R.P., The Extracellular Matrix: An Overview. 2011, Springer, Heidelberg.
2. Hynes, R.O., Yamada, K.M., Extracellular Matrix Biology. 2012, Cold Spring Harbor Perspectives in Biology, New York.
3. Charras, G., Sahai, E., Physical influences of the extracellular environment on cell migration. Nat Rev Mol Cell Biol 15:12 (2014), 813–824.
4. Humphrey, J.D., Dufresne, E.R., Schwartz, M.A., Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 15:12 (2014), 802–812.
5. Hynes, R.O., The extracellular matrix: not just pretty fibrils. Science 326:5957 (2009), 1216–1219.
6. Nelson, C.M., Bissell, M.J., Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22 (2006), 287–309.
7. Aszodi, A., Legate, K.R., Nakchbandi, I., Fassler, R., What mouse mutants teach us about extracellular matrix function. Annu Rev Cell Dev Biol 22 (2006), 591–621.
8. Bateman, J.F., Boot-Handford, R.P., Lamande, S.R., Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat Rev Genet 10:3 (2009), 173–183.
9. Bonnans, C., Chou, J., Werb, Z., Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:12 (2014), 786–801.
10. Didangelos, A., Yin, X., Mandal, K., Saje, A., Smith, A., Xu, Q., Jahangiri, M., Mayr, M., Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics, 10(8), 2011 (M111 008128).
11. Barallobre-Barreiro, J., Didangelos, A., Schoendube, F.A., Drozdov, I., Yin, X., Fernandez-Caggiano, M., Willeit, P., Puntmann, V.O., Aldama-Lopez, G., Shah, A.M., Domenech, N., Mayr, M., Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 125:6 (2012), 789–802.
12. Naba, A., Clauser, K.R., Hoersch, S., Liu, H., Carr, S.A., Hynes, R.O., The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics, 11(4), 2012 (M111 014647).
13. Naba, A., Clauser, K.R., Lamar, J.M., Carr, S.A., Hynes, R.O., Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife, 3, 2014 (e01308).
14. Naba, A., Clauser, K.R., Whittaker, C.A., Carr, S.A., Tanabe, K.K., Hynes, R.O., Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer, 14, 2014, 518.
15. Naba, A., Clauser, K.R., Ding, H., Whittaker, C.A., Carr, S.A., Hynes, R.O., The extracellular matrix: tools and insights for the “omics” era. Matrix Biol 49 (2016), 10–24.
16. Decaris, M.L., Gatmaitan, M., FlorCruz, S., Luo, F., Li, K., Holmes, W.E., Hellerstein, M.K., Turner, S.M., Emson, C.L., Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis. Mol Cell Proteomics 13:7 (2014), 1741–1752.
17. Krasny, L., Paul, A., Wai, P., Howard, B.A., Natrajan, R.C., Huang, P.H., Comparative proteomic assessment of matrisome enrichment methodologies. Biochem J 473:21 (2016), 3979–3995.
18. Gocheva, V., Naba, A., Bhutkar, A., Guardia, T., Miller, K.M., Li, C.M., Dayton, T.L., Sanchez-Rivera, F.J., Kim-Kiselak, C., Jailkhani, N., Winslow, M.M., Del Rosario, A., Hynes, R.O., Jacks, T., Quantitative proteomics identify tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A 114:28 (2017), E5625–E5634.
19. Zhou, Y., Horowitz, J.C., Naba, A., Ambalavanan, N., Atabai, K., Balestrini, J., Bitterman, P.B., Corley, R.A., Ding, B.S., Engler, A.J., Hansen, K.C., Hagood, J.S., Kheradmand, F., Lin, Q.S., Neptune, E., Niklason, L., Ortiz, L.A., Parks, W.C., Tschumperlin, D.J., White, E.S., Chapman, H.A., Thannickal, V.J., Extracellular matrix in lung development, homeostasis and disease. Matrix Biol., 2018, 10.1016/j.matbio.2018.03.005 [Epub ahead of print].
20. Pearce, O.M.T., Delaine-Smith, R.M., Maniati, E., Nichols, S., Wang, J., Bohm, S., Rajeeve, V., Ullah, D., Chakravarty, P., Jones, R.R., Montfort, A., Dowe, T., Gribben, J., Jones, J.L., Kocher, H.M., Serody, J.S., Vincent, B.G., Connelly, J., Brenton, J.D., Chelala, C., Cutillas, P.R., Lockley, M., Bessant, C., Knight, M.M., Balkwill, F.R., Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov 8:3 (2018), 304–319.
21. Hynes, R.O., Naba, A., Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol, 4(1), 2012, a004903.
22. Sullivan, C.A., Chung, G.G., Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques. Clin Colorectal Cancer 7:3 (2008), 172–177.
23. Ramos-Vara, J.A., Miller, M.A., When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry–the red, brown, and blue technique. Vet Pathol 51:1 (2014), 42–87.
24. Taylor, C.R., Predictive biomarkers and companion diagnostics. The future of immunohistochemistry: “in situ proteomics,” or just a “stain”?. Appl Immunohistochem Mol Morphol 22:8 (2014), 555–561.
25. Goldstein, N.S., Hewitt, S.M., Taylor, C.R., Yaziji, H., Hicks, D.G., Members of ad-hoc committee on immunohistochemistry, recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol 15:2 (2007), 124–133.
26. Bordeaux, J., Welsh, A., Agarwal, S., Killiam, E., Baquero, M., Hanna, J., Anagnostou, V., Rimm, D., Antibody validation. Biotechniques 48:3 (2010), 197–209.
27. Baker, M., Reproducibility crisis: blame it on the antibodies. Nature 521:7552 (2015), 274–276.
28. Uhlen, M., Bandrowski, A., Carr, S., Edwards, A., Ellenberg, J., Lundberg, E., Rimm, D.L., Rodriguez, H., Hiltke, T., Snyder, M., Yamamoto, T., A proposal for validation of antibodies. Nat Methods 13:10 (2016), 823–827.
29. Acharya, P., Quinlan, A., Neumeister, V., The ABCs of finding a good antibody: how to find a good antibody, validate it, and publish meaningful data. F1000Res, 6, 2017, 851.
30. Weller, M.G., Ten basic rules of antibody validation. Anal Chem Insights, 13, 2018, 10.1177/1177390118757462.
31. Bradbury, A., Pluckthun, A., Reproducibility: standardize antibodies used in research. Nature 518:7537 (2015), 27–29.
32. Saper, C.B., Sawchenko, P.E., Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465:2 (2003), 161–163.
33. Vasilevsky, N.A., Brush, M.H., Paddock, H., Ponting, L., Tripathy, S.J., Larocca, G.M., Haendel, M.A., On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ, 1, 2013, e148.
34. Voskuil, J.L., The challenges with the validation of research antibodies. F1000Res, 6, 2017, 161.
35. Polakiewicz, R.D., Antibodies: the solution is validation. Nature, 518(7540), 2015, 483.
36. Freedman, L.P., Gibson, M.C., Bradbury, A.R., Buchberg, A.M., Davis, D., Dolled-Filhart, M.P., Lund-Johansen, F., Rimm, D.L., [Letter to the editor] the need for improved education and training in research antibody usage and validation practices. Biotechniques 61:1 (2016), 16–18.
37. Roncador, G., Engel, P., Maestre, L., Anderson, A.P., Cordell, J.L., Cragg, M.S., Serbec, V.C., Jones, M., Lisnic, V.J., Kremer, L., Li, D., Koch-Nolte, F., Pascual, N., Rodriguez-Barbosa, J.I., Torensma, R., Turley, H., Pulford, K., Banham, A.H., The European antibody network's practical guide to finding and validating suitable antibodies for research. MAbs 8:1 (2016), 27–36.
38. Dove, A., Agreeable antibodies: antibody validation challenges and solutions. Science 357 (2017), 1165–1167.
39. Jositsch, G., Papadakis, T., Haberberger, R.V., Wolff, M., Wess, J., Kummer, W., Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 379:4 (2009), 389–395.
40. D'Amico, F., Skarmoutsou, E., Stivala, F., State of the art in antigen retrieval for immunohistochemistry. J Immunol Methods 341:1–2 (2009), 1–18.
41. Howat, W.J., Lewis, A., Jones, P., Kampf, C., Ponten, F., van der Loos, C.M., Gray, N., Womack, C., Warford, A., Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods 70:1 (2014), 34–38.
42. Shi, S.R., Key, M.E., Kalra, K.L., Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:6 (1991), 741–748.
43. Shi, S.R., Cote, R.J., Yang, C., Chen, C., Xu, H.J., Benedict, W.F., Taylor, C.R., Development of an optimal protocol for antigen retrieval: a ‘test battery’ approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections. J Pathol 179:3 (1996), 347–352.
44. Camp, R.L., Neumeister, V., Rimm, D.L., A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 26:34 (2008), 5630–5637.
45. Hewitt, S.M., Baskin, D.G., Frevert, C.W., Stahl, W.L., Rosa-Molinar, E., Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays. J Histochem Cytochem 62:10 (2014), 693–697.
46. Franciosi, S., De Gasperi, R., Dickstein, D.L., English, D.F., Rocher, A.B., Janssen, W.G., Christoffel, D., Sosa, M.A., Hof, P.R., Buxbaum, J.D., Elder, G.A., Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. J Neurosci Methods 163:1 (2007), 76–82.
47. Aumailley, M., Bruckner-Tuderman, L., Carter, W.G., Deutzmann, R., Edgar, D., Ekblom, P., Engel, J., Engvall, E., Hohenester, E., Jones, J.C., Kleinman, H.K., Marinkovich, M.P., Martin, G.R., Mayer, U., Meneguzzi, G., Miner, J.H., Miyazaki, K., Patarroyo, M., Paulsson, M., Quaranta, V., Sanes, J.R., Sasaki, T., Sekiguchi, K., Sorokin, L.M., Talts, J.F., Tryggvason, K., Uitto, J., Virtanen, I., von der Mark, K., Wewer, U.M., Yamada, Y., Yurchenco, P.D., A simplified laminin nomenclature. Matrix Biol 24:5 (2005), 326–332.
48. Pozzi, A., Yurchenco, P.D., Iozzo, R.V., The nature and biology of basement membranes. Matrix Biol 57-58 (2017), 1–11.
49. Randles, M.J., Humphries, M.J., Lennon, R., Proteomic definitions of basement membrane composition in health and disease. Matrix Biol 57-58 (2017), 12–28.
50. Raats, C.J., Bakker, M.A., Hoch, W., Tamboer, W.P., Groffen, A.J., van den Heuvel, L.P., Berden, J.H., van den Born, J., Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273:28 (1998), 17832–17838.
51. Suleiman, H., Zhang, L., Roth, R., Heuser, J.E., Miner, J.H., Shaw, A.S., Dani, A., Nanoscale protein architecture of the kidney glomerular basement membrane. Elife, 2, 2013, e01149.
52. Roper, J., Tammela, T., Cetinbas, N.M., Akkad, A., Roghanian, A., Rickelt, S., Almeqdadi, M., Wu, K., Oberli, M.A., Sanchez-Rivera, F.J., Park, Y.K., Liang, X., Eng, G., Taylor, M.S., Azimi, R., Kedrin, D., Neupane, R., Beyaz, S., Sicinska, E.T., Suarez, Y., Yoo, J., Chen, L., Zukerberg, L., Katajisto, P., Deshpande, V., Bass, A.J., Tsichlis, P.N., Lees, J., Langer, R., Hynes, R.O., Chen, J., Bhutkar, A., Jacks, T., Yilmaz, O.H., In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol 35:6 (2017), 569–576.
53. Uhlen, M., Fagerberg, L., Hallstrom, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, A., Kampf, C., Sjostedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C.A., Odeberg, J., Djureinovic, D., Takanen, J.O., Hober, S., Alm, T., Edqvist, P.H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J.M., Hamsten, M., von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., von Heijne, G., Nielsen, J., Ponten, F., Proteomics. Tissue-based map of the human proteome. Science, 347(6220), 2015, 1260419.
54. Thul, P.J., Akesson, L., Wiking, M., Mahdessian, D., Geladaki, A., Ait Blal, H., Alm, T., Asplund, A., Bjork, L., Breckels, L.M., Backstrom, A., Danielsson, F., Fagerberg, L., Fall, J., Gatto, L., Gnann, C., Hober, S., Hjelmare, M., Johansson, F., Lee, S., Lindskog, C., Mulder, J., Mulvey, C.M., Nilsson, P., Oksvold, P., Rockberg, J., Schutten, R., Schwenk, J.M., Sivertsson, A., Sjostedt, E., Skogs, M., Stadler, C., Sullivan, D.P., Tegel, H., Winsnes, C., Zhang, C., Zwahlen, M., Mardinoglu, A., Ponten, F., von Feilitzen, K., Lilley, K.S., Uhlen, M., Lundberg, E., A subcellular map of the human proteome. Science, 356(6340), 2017.
55. Thul, P.J., Lindskog, C., The human protein atlas: a spatial map of the human proteome. Protein Sci 27:1 (2018), 233–244.
56. G.T. Consortium, The genotype-tissue expression (GTEx) project. Nat Genet 45:6 (2013), 580–585.
57. Chautard, E., Ballut, L., Thierry-Mieg, N., Ricard-Blum, S., MatrixDB, a database focused on extracellular protein-protein and protein-carbohydrate interactions. Bioinformatics 25:5 (2009), 690–691.
58. Launay, G., Salza, R., Multedo, D., Thierry-Mieg, N., Ricard-Blum, S., MatrixDB, the extracellular matrix interaction database: updated content, a new navigator and expanded functionalities. Nucleic Acids Res 43:Database issue (2015), D321–7.
59. Eusebio, A., Oliveri, F., Barzaghi, P., Ruegg, M.A., Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscul Disord 13:5 (2003), 408–415.
60. Hedbom, E., Antonsson, P., Hjerpe, A., Aeschlimann, D., Paulsson, M., Rosa-Pimentel, E., Sommarin, Y., Wendel, M., Oldberg, A., Heinegard, D., Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:9 (1992), 6132–6136.
61. Gardner, J.M., Hynes, R.O., Interaction of fibronectin with its receptor on platelets. Cell 42:2 (1985), 439–448.
62. Hynes, R.O., Destree, A.T., Relationships between fibronectin (LETS protein) and actin. Cell 15:3 (1978), 875–886.
63. Peters, J.H., Sporn, L.A., Ginsberg, M.H., Wagner, D.D., Human endothelial cells synthesize, process, and secrete fibronectin molecules bearing an alternatively spliced type III homology (ED1). Blood 75:9 (1990), 1801–1808.
64. Peters, J.H., Trevithick, J.E., Johnson, P., Hynes, R.O., Expression of the alternatively spliced EIIIB segment of fibronectin. Cell Adhes Commun 3:1 (1995), 67–89.
65. Hyytiainen, M., Taipale, J., Heldin, C.H., Keski-Oja, J., Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem 273:32 (1998), 20669–20676.
66. Brown, L.F., Berse, B., Van de Water, L., Papadopoulos-Sergiou, A., Perruzzi, C.A., Manseau, E.J., Dvorak, H.F., Senger, D.R., Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:10 (1992), 1169–1180.